Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/11/27 00:29:17」(JST)
[Wiki en表示]
Urocortin |
Rendering based on PDB 2RMF.
|
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
2RMF, 3N96
|
|
|
Identifiers |
Symbols |
UCN ; UI; UROC |
External IDs |
OMIM: 600945 MGI: 1276123 HomoloGene: 2515 GeneCards: UCN Gene |
Gene ontology |
Molecular function |
• neuropeptide hormone activity
• protein binding
• histone deacetylase inhibitor activity
• corticotropin-releasing hormone receptor 1 binding
• corticotropin-releasing hormone receptor 2 binding
|
Cellular component |
• extracellular region
• dendrite
• varicosity
• perikaryon
• axon terminus
|
Biological process |
• inflammatory response
• response to oxidative stress
• G-protein coupled receptor signaling pathway
• neuropeptide signaling pathway
• female pregnancy
• sensory perception of sound
• associative learning
• aerobic respiration
• negative regulation of gene expression
• pancreatic juice secretion
• positive regulation of cell growth
• positive regulation of cAMP biosynthetic process
• negative regulation of histone deacetylation
• neuron projection development
• negative regulation of appetite
• response to estradiol
• positive regulation of interleukin-6 production
• positive regulation of collagen biosynthetic process
• positive regulation of peptidyl-serine phosphorylation
• activation of protein kinase A activity
• social behavior
• gastric emptying
• drinking behavior
• negative regulation of apoptotic process
• positive regulation of vascular permeability
• positive regulation of translation
• positive regulation of DNA replication
• negative regulation of blood pressure
• negative regulation of cell size
• positive regulation of vasodilation
• negative regulation of hormone secretion
• response to pain
• response to glucocorticoid
• positive regulation of corticotropin secretion
• regulation of synaptic transmission, glutamatergic
• positive regulation of cardiac muscle contraction
• negative regulation of gastric acid secretion
• negative regulation of necrotic cell death
• positive regulation of calcium ion import
• negative regulation of neuron death
• negative regulation of feeding behavior
• positive regulation of behavioral fear response
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
Entrez |
7349 |
22226 |
Ensembl |
ENSG00000163794 |
ENSMUSG00000038676 |
UniProt |
P55089 |
P81615 |
RefSeq (mRNA) |
NM_003353 |
NM_021290 |
RefSeq (protein) |
NP_003344 |
NP_067265 |
Location (UCSC) |
Chr 2:
27.31 – 27.31 Mb |
Chr 5:
31.14 – 31.14 Mb |
PubMed search |
[1] |
[2] |
|
Urocortin is a protein that in humans is encoded by the UCN gene.[1][2][3]
Contents
- 1 Function
- 2 Interactions
- 3 References
- 4 Further reading
Function
This gene is a member of the sauvagine/corticotropin-releasing factor/urotensin I family. It is structurally related to the corticotropin-releasing factor (CRF) gene and the encoded product is an endogenous ligand for CRF type 2 receptors. In the brain, it may be responsible for the effects of stress on appetite. In spite of the gene family name similarity, the product of this gene has no sequence similarity to urotensin II.[3]
Urocortin is a potent anorexigenic peptide of 40 amino acids that induces fed-like motor activity when administered centrally or peripherally in fasted animals. Urocortin belongs to the corticotropin-releasing factor (CRF) family that includes CRF, urotensin I, sauvagine, urocortin II and urocortin III. Urocortin is also a potent and long-lasting hypotensive agent and increases coronary blood flow.
Interactions
Urocortin has been shown to interact with Corticotropin releasing hormone receptor 1.[4][5]
References
- ^ Zhao L, Donaldson CJ, Smith GW, Vale WW (April 1999). "The structures of the mouse and human urocortin genes (Ucn and UCN)". Genomics 50 (1): 23–33. doi:10.1006/geno.1998.5292. PMID 9628819.
- ^ Tsarev OB (July 1977). "[Dynamics of matrix synthesis in molecular biophysics. II. Principle of insertability and the single-valued solution of feedback tasks]". Biofizika 22 (2): 197–200. PMID 861256.
- ^ a b "Entrez Gene: UCN urocortin".
- ^ Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW (May 1996). "Cloning and characterization of human urocortin". Endocrinology 137 (5): 2167–70. doi:10.1210/en.137.5.2167. PMID 8612563.
- ^ Gottowik J, Goetschy V, Henriot S, Kitas E, Fluhman B, Clerc RG, Moreau JL, Monsma FJ, Kilpatrick GJ (October 1997). "Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin". Neuropharmacology 36 (10): 1439–46. doi:10.1016/S0028-3908(97)00098-1. PMID 9423932.
Further reading
- Inui A, Asakawa A, Bowers CY, Mantovani G, Laviano A, Meguid MM, Fujimiya M (Mar 2004). "Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ". FASEB J 18 (3): 439–56. doi:10.1096/fj.03-0641rev. PMID 15003990.
- Huang Y, Yao XQ, Lau CW, Chan YC, Tsang SY, Chan FL (Mar 2004). "Urocortin and cardiovascular protection". Acta Pharmacol Sin. 25 (3): 257–65.
- Takahashi, Kazuhiro (2004). "Translational medicine in fish-derived peptides: From fish endocrinology to human physiology and diseases". Endocrine Journal (Kyoto, Japan) 51 (1): 1–17. doi:10.1507/endocrj.51.1.
- Adachi T, Schamel WW, Kim KM, Watanabe T, Becker B, Nielsen PJ, Reth M (1996). "The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence.". EMBO J. 15 (7): 1534–41. PMC 450061. PMID 8612576.
- Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Totsune K, Takahashi K, Suzuki H, Nagura H, Yoshimi T (1997). "Urocortin expression in human pituitary gland and pituitary adenoma.". J. Clin. Endocrinol. Metab. 82 (11): 3842–50. doi:10.1210/jc.82.11.3842. PMID 9360550.
- Gottowik J, Goetschy V, Henriot S, Kitas E, Fluhman B, Clerc RG, Moreau JL, Monsma FJ, Kilpatrick GJ (1998). "Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.". Neuropharmacology 36 (10): 1439–46. doi:10.1016/S0028-3908(97)00098-1. PMID 9423932.
- Bamberger CM, Wald M, Bamberger AM, Ergün S, Beil FU, Schulte HM (1998). "Human lymphocytes produce urocortin, but not corticotropin-releasing hormone.". J. Clin. Endocrinol. Metab. 83 (2): 708–11. doi:10.1210/jc.83.2.708. PMID 9467598.
- Takahashi K, Totsune K, Sone M, Murakami O, Satoh F, Arihara Z, Sasano H, Iino K, Mouri T (1998). "Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain.". Peptides 19 (4): 643–7. doi:10.1016/S0196-9781(98)00012-6. PMID 9622018.
- Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Takahashi K, Suzuki H, Tezuka F, Yoshimi T, Nagura H (1999). "Urocortin expression in the human central nervous system.". Clin. Endocrinol. (Oxf) 50 (1): 107–14. doi:10.1046/j.1365-2265.1999.00624.x. PMID 10341863.
- Watanabe F, Oki Y, Ozawa M, Masuzawa M, Iwabuchi M, Yoshimi T, Nishiguchi T, Iino K, Sasano H (1999). "Urocortin in human placenta and maternal plasma.". Peptides 20 (2): 205–9. doi:10.1016/S0196-9781(98)00175-2. PMID 10422876.
- Slominski A, Roloff B, Curry J, Dahiya M, Szczesniewski A, Wortsman J (2000). "The skin produces urocortin.". J. Clin. Endocrinol. Metab. 85 (2): 815–23. doi:10.1210/jc.85.2.815. PMID 10690896.
- Muramatsu Y, Fukushima K, Iino K, Totsune K, Takahashi K, Suzuki T, Hirasawa G, Takeyama J, Ito M, Nose M, Tashiro A, Hongo M, Oki Y, Nagura H, Sasano H (2001). "Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa.". Peptides 21 (12): 1799–809. doi:10.1016/S0196-9781(00)00335-1. PMID 11150640.
- Muramatsu Y, Sugino N, Suzuki T, Totsune K, Takahashi K, Tashiro A, Hongo M, Oki Y, Sasano H (2001). "Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries.". J. Clin. Endocrinol. Metab. 86 (3): 1362–9. doi:10.1210/jc.86.3.1362. PMID 11238533.
- Hsu SY, Hsueh AJ (2001). "Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.". Nat. Med. 7 (5): 605–11. doi:10.1038/87936. PMID 11329063.
- Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW (2001). "Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.". Proc. Natl. Acad. Sci. U.S.A. 98 (13): 7570–5. doi:10.1073/pnas.121165198. PMC 34709. PMID 11416224.
- Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H (2002). "Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.". J. Clin. Endocrinol. Metab. 87 (1): 340–6. doi:10.1210/jc.87.1.340. PMID 11788672.
- Florio P, Arcuri F, Ciarmela P, Runci Y, Romagnoli R, Cintorino M, Di Blasio AM, Petraglia F (2002). "Identification of urocortin mRNA and peptide in the human endometrium.". J. Endocrinol. 173 (2): R9–14. doi:10.1677/joe.0.173R009. PMID 12010647.
- Arcuri F, Cintorino M, Florio P, Floccari F, Pergola L, Romagnoli R, Petraglia F, Tosi P, Teresa Del Vecchio M (2002). "Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma.". Prostate 52 (3): 167–72. doi:10.1002/pros.10094. PMID 12111693.
- Ikeda K, Tojo K, Oki Y, Nakao K (2002). "Urocortin has cell-proliferative effects on cardiac non-myocytes.". Life Sci. 71 (16): 1929–38. doi:10.1016/S0024-3205(02)01945-8. PMID 12175707.
Neuropeptidergics
|
|
CGRP |
- Agonists: Amylin
- CGRP
- Pramlintide
- Antagonists: BI 44370 TA
- BMS-927711
- CGRP (8-37)
- MK-3207
- Olcegepant
- Rimegepant
- SB-268262
- Telcagepant
- Ubrogepant
|
|
Cholecystokinin |
CCKA
|
- Agonists: Cholecystokinin
- CCK-4
- Antagonists: Amiglumide
- Asperlicin
- Devazepide
- Dexloxiglumide
- Lintitript
- Lorglumide
- Loxiglumide
- Pranazepide
- Proglumide
- Tarazepide
- Tomoglumide
|
|
CCKB
|
- Agonists: Cholecystokinin
- CCK-4
- Gastrin
- Antagonists: CI-988 (PD-134,308)
- Itriglumide
- L-365,360
- Netazepide
- Proglumide
- Spiroglumide
|
|
Unsorted
|
- Antagonists: Nastorazepide
|
|
|
CRH |
CRF1
|
- Agonists: Cortagine
- Corticorelin
- Corticotropin releasing hormone
- Sauvagine
- Stressin I
- Urocortin
- Antagonists: Antalarmin
- Astressin-B
- CP-154,526
- Emicerfont
- Hypericin
- LWH-234
- NBI-27914
- Pexacerfont
- R-121,919
- TS-041
- Verucerfont
|
|
CRF2
|
- Agonists: Corticorelin
- Corticotropin releasing hormone
- Sauvagine
- Urocortin
|
|
|
Galanin |
GAL1
|
- Agonists: Galanin
- Galanin (1-15)
- Galanin-like peptide
- Galmic
- Galnon
- Antagonists: C7
- Dithiepine-1,1,4,4-tetroxide
- Galantide (M15)
- M32
- M35
- M40
- SCH-202596
|
|
GAL2
|
- Agonists: Galanin
- Galanin (1-15)
- Galanin (2-11)
- Galanin-like peptide
- Galmic
- Galnon
- J18
- Antagonists: C7
- Galantide (M15)
- M32
- M35
- M40
- M871
|
|
GAL3
|
- Agonists: Galanin
- Galanin (1-15)
- Galmic
- Galnon
- Antagonists: C7
- Galantide (M15)
- GalR3ant
- HT-2157
- M32
- M35
- M40
- SNAP-37889
- SNAP-398299
|
|
|
Ghrelin/GHS |
- Agonists: Adenosine
- Alexamorelin
- Anamorelin
- Capromorelin
- CP-464709
- Cortistatin-14
- Examorelin (hexarelin)
- Ghrelin (lenomorelin)
- GHRP-1
- GHRP-3
- GHRP-4
- GHRP-5
- GHRP-6
- Ibutamoren (MK-677)
- Ipamorelin
- L-692,585
- LY-426410
- LY-444711
- Macimorelin
- Pralmorelin (GHRP-2)
- Relamorelin
- SM-130,686
- Tabimorelin
- Ulimorelin
- Antagonists: A-778,193
- Cortistatin-8
- (D-Lys3)-GHRP-6
- YIL-781
|
|
MCH |
MCH1
|
- Agonists: Melanin concentrating hormone
- Antagonists: ATC-0065
- ATC-0175
- GW-803,430
- NGD-4715
- SNAP-7941
- SNAP-94847
|
|
MCH2
|
- Agonists: Melanin concentrating hormone
|
|
|
Melanocortin |
MC1
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- BMS-470,539
- Bremelanotide
- HS-014
- HS-024
- Melanotan II
- Modimelanotide
- PL-8177
- SHU-8914
- SHU-9005
- SHU-9119
- SNAP-7941
|
|
MC2
|
- Agonists: ACTH (corticotropin)
- Alsactide
- Codactide
- Giractide
- Norleusactide (pentacosactride)
- Seractide
- Tetracosactide (tetracosactrin, cosyntropin)
- Tosactide (octacosactrin)
- Tricosactide
- Tridecactide
|
|
MC3
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- Bremelanotide
- Melanotan II
- Modimelanotide
- PG-931
- Antagonists: AGRP
- ASIP
- HS-014
- ML-00253764
- PG-106
- SHU-8914
- SHU-9005
- SHU-9119
|
|
MC4
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- AZD2820
- BIM-22493
- Bremelanotide
- LY-2112688
- Melanotan II
- MK-0493
- Modimelanotide
- PF-00446687
- PG-931
- PL-6983
- Ro 27-3225
- Setmelanotide
- THIQ
- Antagonists: AGRP
- ASIP
- HS-014
- HS-024
- HS-131
- JKC-363
- MCL-0020
- MCL-0042
- MCL-0129
- ML-00253764
- MPB-10
- SHU-8914
- SHU-9005
- SHU-9119
|
|
MC5
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- Bremelanotide
- HS-014
- HS-024
- Melanotan II
- Modimelanotide
- SHU-8914
- SHU-9005
- SHU-9119
- Antagonists: ASIP
- ML-00253764
|
|
Unsorted
|
- Agonists: Alsactide
- Codactide
- Giractide
- Norleusactide (pentacosactride)
- Seractide
- Tetracosactide (tetracosactrin, cosyntropin)
- Tosactide (octacosactrin)
- Tricosactide
- Tridecactide
|
|
|
Neuropeptide FF |
- Agonists: Neuropeptide AF
- Neuropeptide FF
- Neuropeptide SF (RFRP-1)
- Neuropeptide VF (RFRP-3)
- Antagonists: BIBP-3226
- RF9
|
|
Neuropeptide S |
- Antagonists: ML-154
- SHA-68
|
|
Neuropeptide Y |
Y1
|
- Agonists: Neuropeptide Y
- Peptide YY
- Antagonists: BIBO-3304
- BIBP-3226
- BVD-10
- GR-231,118
- PD-160,170
|
|
Y2
|
- Agonists: 2-Thiouridine 5'-triphosphate
- Neuropeptide Y
- Neuropeptide Y (13-36)
- Peptide YY
- Peptide YY (3-36)
- Antagonists: BIIE-0246
- JNJ-5207787
- SF-11
|
|
Y4
|
- Agonists: GR-231,118
- Neuropeptide Y
- Pancreatic polypeptide
- Peptide YY
|
|
Y5
|
- Agonists: BWX-46
- Neuropeptide Y
- Peptide YY
- Antagonists: CGP-71683
- FMS-586
- L-152,804
- Lu AA-33810
- MK-0557
- NTNCB
- Velneperit (S-2367)
|
|
|
Neurotensin |
NTS1
|
- Agonists: Neurotensin
- Neuromedin N
- Antagonists: Meclinertant
- SR-142,948
|
|
NTS2
|
- Antagonists: Levocabastine
- SR-142,948
|
|
|
Opioid |
See here instead.
|
|
Orexin |
OX1
|
- Agonists: Orexin-A
- Orexin-B
- Antagonists: ACT-335827
- ACT-462206
- Almorexant
- Filorexant
- Lemborexant
- SB-334,867
- SB-408,124
- SB-649,868
- Suvorexant
- TCS-1102
|
|
OX2
|
- Agonists: Orexin-A
- Orexin-B
- SB-668,875
- Antagonists: ACT-335827
- ACT-462206
- Almorexant
- EMPA
- Filorexant
- JNJ-10397049
- JNJ-42847922
- Lemborexant
- MK-1064
- SB-649,868
- Suvorexant
- TCS-1102
- TCS-OX2-29
|
|
|
Oxytocin |
- Agonists: Aspartocin
- Carbetocin
- Cargutocin
- Demoxytocin
- Lipo-oxytocin-1
- Merotocin
- Nacartocin
- Oxytocin
- TC OT 39
- TGOT
- Vasotocin (argiprestocin)
- WAY-267,464
- Antagonists: Atosiban
- Barusiban
- Epelsiban
- Erlosiban
- L-368,899
- L-371,257
- L-372,662
- OBE001
- Retosiban
- SSR-126,768
- Tocinoic acid
- WAY-162,720
- Metabolism inhibitors: Amastatin
- Bestatin (ubenimex)
- EDTA
- L-Methionine
- Leupeptin
- o-Phenanthroline
- Phosphoramidon
- Puromycin
|
|
Tachykinin |
NK1
|
- Antagonists: Aprepitant
- Befetupitant
- Burapitant
- Casopitant
- CI-1021
- CP-96,345
- CP-99,994
- CP-122,721
- Dapitant
- Ezlopitant
- Figopitant
- FK-888
- Fosaprepitant
- Fosnetupitant
- GR-203,040
- GW-597,599
- HSP-117
- L-733,060
- L-741,671
- L-743,310
- L-758,298
- Lanepitant
- LY-306,740
- Maropitant
- Netupitant
- NKP-608
- Nolpitantium besilate
- Orvepitant
- Rolapitant
- RP-67,580
- SDZ NKT 343
- Serlopitant
- Telmapitant
- Tradipitant
- Vestipitant
- Vofopitant
|
|
NK2
|
- Antagonists: GR-159,897
- Ibodutant
- Nepadutant
- Saredutant
|
|
NK3
|
- Antagonists: Osanetant
- Talnetant
|
|
|
Vasopressin |
V1A
|
- Agonists: Felypressin
- Lypressin
- Ornipressin
- Selepressin
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: Atosiban
- Conivaptan
- FR-218944
- JNJ-17079166
- JNJ-17308616
- LY-307174
- PF-184563
- Relcovaptan
- RG7314
- SRX246
- SRX251
- TC OT 39
- WAY-267,464
- YM-218
- YM-471
- YM-35471
|
|
V1B
|
- Agonists: Desmopressin
- Felypressin
- Lypressin
- Ornipressin
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: ABT-436
- Nelivaptan
- ORG-52186
|
|
V2
|
- Agonists: Desmopressin
- Felypressin
- Lypressin
- Ornipressin
- TC OT 39
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: Conivaptan
- JNJ-17079166
- Lixivaptan
- Mozavaptan
- RWJ-351647
- Satavaptan
- Tolvaptan
- YM-471
- YM-35471
|
|
Unsorted
|
- Antagonists: Ribuvaptan
- RWJ-339489
- VMAX-367
- VMAX-372
- VMAX-382
- YM-222546
|
|
|
See also: Peptidergics
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala: Amygdalar angiotensin receptors and panic.
- Johnson PL, Sajdyk TJ, Fitz SD, Hale MW, Lowry CA, Hay-Schmidt A, Shekhar A.SourceDepartment of Anatomy & Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States; Institute of Psychiatric Research Departments of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, United States.
- Progress in neuro-psychopharmacology & biological psychiatry.Prog Neuropsychopharmacol Biol Psychiatry.2013 Jul;44:248-56. doi: 10.1016/j.pnpbp.2013.02.014. Epub 2013 Mar 21.
- Rats treated with three daily urocortin 1 (UCN) injections into the basolateral amygdala (BLA; i.e., UCN/BLA-primed rats) develop prolonged anxiety-associated behavior and vulnerability to panic-like physiological responses (i.e., tachycardia, hypertension and tachypnea) following intravenous infusi
- PMID 23523745
- Urocortin increased LPS-induced endothelial permeability by regulating the cadherin-catenin complex via corticotrophin-releasing hormone receptor 2.
- Wan R, Guo R, Chen C, Jin L, Zhu C, Zhang Q, Xu Y, Li S.SourceDepartment of Pharmacology, Jiangsu Provincial Key Lab of Cardiovascular Diseases and Molecular Intervention, Nanjing Medical University, Nanjing, P.R. China.
- Journal of cellular physiology.J Cell Physiol.2013 Jun;228(6):1295-303. doi: 10.1002/jcp.24286.
- Urocortin (Ucn1), a member of corticotrophin-releasing hormone (CRH) family, has been reported to be upregulated in inflammatory diseases and function as an autocrine or paracrine inflammatory mediator. Growing evidence shows that Ucn1 increases the endothelial permeability in inflammatory condition
- PMID 23168683
- Cellular insulin resistance disrupts leptin-mediated control of neuronal signaling and transcription.
- Nazarians-Armavil A, Menchella JA, Belsham DD.SourcePhD, Department of Physiology, University of Toronto, Medical Sciences Building 3247A, 1 Kings College Circle, Toronto, Ontario, Canada M5S 1A8. d.belsham@utoronto.ca.
- Molecular endocrinology (Baltimore, Md.).Mol Endocrinol.2013 Jun;27(6):990-1003. doi: 10.1210/me.2012-1338. Epub 2013 Apr 11.
- Central resistance to the actions of insulin and leptin is associated with the onset of obesity and type 2 diabetes mellitus, whereas leptin and insulin signaling is essential for both glucose and energy homeostasis. Although it is known that leptin resistance can lead to attenuated insulin signalin
- PMID 23579487
Japanese Journal
- Urocortin Iの心筋細胞における抗酸化作用の検討 (第129回成医会総会一般演題)
- ACTH response to desmopressin in a patient with acromegaly ; Expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma
- ARIHARA Zenei,SAKURAI Kanako,OSAKI Yoshinori,FUKAZAWA Hiroshi,YAMADA Shozo,INOSHITA Naoko,MURAKAMI Osamu,OHBA Koji,TAKAHASHI Kazuhiro
- Endocrine journal 58(12), 1029-1036, 2011-12-01
- NAID 10030392435
- ストレス (特集 日常的な健康問題におけるCRF-ACTH-コルチゾール系の重要性)
Related Links
- ... 38–amino acid peptide that represented a new member of the CRF peptide family, which was termed urocortin II. The biological importance in cardiovascular regulation of urocortin II was significantly advanced 3 who reported ...
- Human Urocortin II, a Selective Agonist for the Type 2 Corticotropin-Releasing Factor Receptor, Decreases Feeding and Drinking in the Rat Corticotropin-releasing ...
Related Pictures